wild aces online casino

Amid Political Turbulence, US Lawyers Need to Bolster Respect for the Rule of LawIowa St., Arizona St. meet for Big 12 championship

( MENAFN - KNN India) New Delhi, Nov 30 (KNN) The Confederation of Indian industry (CII) has projected significant growth potential for India's medical technology industry, anticipating exports could reach up to USD 20 billion by 2030. However, this ambitious target hinges on crucial government support and strategic policy interventions. Currently, India faces a substantial trade imbalance in medical equipment. The country imports approximately 60 to 70 percent of its medical technologies, with domestic manufacturing accounting for only around 30 percent. Imports stand at roughly USD 8 billion, while exports hover near USD 4 billion. Himanshu Baid, Chairman of the CII National Medical Technology Forum, highlighted India's strategic advantages in this sector. The country is well-positioned to capitalize on the global 'China plus one' strategy, leveraging its strengths in software development, hardware engineering, and cost-competitive labor. To realize this export potential, the industry is calling for several key policy reforms. These include extending the Production Linked Incentive (PLI) scheme across more medical technology products, enhancing export incentives, and addressing regulatory complexities. Baid emphasized the need for a separate regulatory framework for medical devices, which currently falls under the pharmaceutical sector's regulatory umbrella. The industry also seeks modifications to existing regulations. Specifically, the Quality Control Order (QCO) requirements for raw material suppliers pose significant challenges for local manufacturers. Baid argued that these regulations create barriers for small suppliers attempting to register globally. Export infrastructure improvement is another critical area of focus. The industry wants to reduce shipping delays, comparing India's current two to three-week container shipping timeline unfavorably with China's more efficient two to three-day process. The CII recommends increasing export incentives under the Remission of Duties and Taxes on Export Products (RoDTEP) scheme from the current 0.5-0.7 percent to 2-2.5 percent. This adjustment would help manufacturers offset hidden costs and improve international competitiveness. Of the existing PLI scheme for medical devices, only 28 companies have been allocated funds, with merely 10 to 20 percent of the Rs 3,400 crore budget utilized. The industry urges the government to expand the scheme's scope and more aggressively support domestic manufacturing and export initiatives. As India seeks to transform its medical technology landscape, these proposed interventions could be pivotal in reducing import dependence and establishing the country as a global medical technology manufacturing and export hub. (KNN Bureau) MENAFN30112024000155011030ID1108941701 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

None

None( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Nov. 30, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Chipotle Mexican Grill, Inc. (NYSE: CMG) between February 8, 2024 and October 29, 2024, both dates inclusive (the“Class Period”) and those who purchased Chipotle call options or sold put options during the Class Period, of the important January 10, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Chipotle securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Chipotle class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email ... for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 10, 2025 . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Chipotle's portion sizes were inconsistent and left many customers dissatisfied with the Company's offerings; (2) in order to address the issue and retain customer loyalty, Chipotle would have to ensure more generous portion sizes, which would increase cost of sales; and (3) as a result, defendants' statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Chipotle class action, go to call Phillip Kim, Esq. toll-free at 866-767-3653 or email ... for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: or on Twitter: or on Facebook: . Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 ... MENAFN30112024004107003653ID1108941539 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.Aidan O'Connell shows in loss to Chiefs that he is the Raiders' QB for the rest of season

Rivian Automotive ( RIVN 4.85% ) has made a name for itself in the increasingly crowded electric vehicle (EV) field with its limited vehicle lineup. The company has focused on producing just a fully electric pickup truck, an SUV, and a commercial delivery van. That focus may have much to do with why Rivian shares are marching higher today. Rivian's R1T is one of just a few electric pickup truck offerings. Tesla has entered the market with its unique Cybertruck, but the R1T's biggest competition is arguably Ford 's F-150 Lightning. And it's news about the Ford EV that may have had Rivian stock jumping by nearly 10% Friday morning. At 1:55 p.m. ET, Rivian shares still held on to a gain of 4.5%. The move has helped Rivian stock log an increase of more than 20% in the last month. Rivian's gaining momentum Last month, Rivian told investors it expects to deliver between 50,500 and 52,000 EVs this year. That would only slightly surpass 2023 deliveries. But the company also recently provided encouraging news related to its future capital position. And it is preparing to start production of its next-generation R2 platform next year as well. That has bolstered the stock recently, and yesterday it got another boost when Ford released its November vehicle sales update. That's because sales of Ford's F-150 Lightning plunged by 17% last month year over year. Ford has been throttling production plans for its fully electric models and leaning more on its internal combustion lineup as well as hybrid electric models. That's less competition for Rivian and its R1T truck. And yesterday's November update from Ford was a data point supporting that scenario. Rivian was already gaining momentum from announcements last month about plans for a $5.8 billion investment from Volkswagen Group and the potential for up to $6.6 billion in additional financing via a U.S. Department of Energy loan. With a bolstered balance sheet and less competition from Ford's electric pickup, Rivian is set up for a potentially promising 2025.FuriosaAI Ends 2024 on a High Note: Llama 3.1 Performance, SDK Release, Leadership ExpansionChina's getting a big electric car battery swapping boost in 2025. Would that work across the globe?

Breakfast with Jimmy Carter in a tense KhartoumChase to break 96-year-old record in hands for India to win MCG Test